Efficacy of Mesenchymal Stem Cells (MScs) enhanced with Platelet Rich Plasma PRP in Osteoarthritis (OA) Treatment
Journal Title: IP International Journal of Orthopaedic Rheumatology - Year 2017, Vol 3, Issue 1
Abstract
Osteoarthritis (OA) is one of the most common joint diseases. This disease commonly develops in the weight bearing joints of the lower limbs, such as the knee and hip joints. Osteoarthritis is considered a chronic degenerative disorder that is characterized by a loss of articular cartilage and it causes detrimental effects on the quality of life and functional status. There is no effective therapy available today that alters the pathobiologic course of the disease. Platelet-rich plasma (PRP), which can be easily isolated from whole blood, is often used for bone regeneration, wound healing and bone defect repair. Platelets contain significant amounts of cytokines and growth factors which are capable of stimulating cellular growth, vascularization, proliferation, tissue regeneration, and collagen synthesis. When stem cells are combined with PRP in the presence of GFs, they are able to promote osteogenesis. A growing interest in the area of regenerative medicine, led by an improved understanding of the role of Mesenchymal Stem Cells (MSCs) in tissue homeostasis and repair, has also been recent focused efforts to explore the potential of stem cell therapies in the active management of symptomatic osteoarthritis. Encouragingly, results of pre-clinical and clinical trials have provided initial evidence of efficacy and indicated safety in the therapeutic use of mesenchymal stem cell therapies for the treatment of knee osteoarthritis. Moreover influences of PRP on proliferation, migration, stemness, preservation of MSC immune-modulatory properties and appearance of senescence phenotype have been explored. This review provides deeply knowledge regarding the use of MSCs and PRP for the treatment of osteoarthritis and their application in clinical studies for the future.
Authors and Affiliations
Parizad Patel, Kanjaksha Ghosh, Kanchan K. Mishra
Keywords
Related Articles
- EP ID EP298350
- DOI 10.18231/2455-6777 .2017.0001
- Views 87
- Downloads 0
Intra-articular injection of bone marrow concentrate protocol for Osteoarthritis – A preliminary report with 12 months follow up
Osteoarthritis – a degenerative joint disorder by loss of cartilage leading to pain and physical function of the patients. Most existing Intra articular injections show promising results in pain relief but none have rege...
Rehabilitation of ACL injuries after surgical reconstruction- Comparison of supervised vs unsupervised rehabilitation
Anterior Cruciate Ligament (ACL) injury is the most common ligament injury of the knee and is common in persons playing regular sports. Complete ACL tear leads to instability which in most cases is noncompliant with comp...
Viscosupplementation-the concept in alleviating symptoms of temporomandibular joint osteoarthritis: A clinical study
Abstract Purpose: The aim of the present study was to evaluate the efficacy of hyaluronidase injection in the treatment of temporomandibular joint osteoarthritis. Patients and Methods: Patients with symptoms of unilatera...
Ultrasound-guided steroid injection: A scintillating dimension in managing de Quervain's tenosynovitis
Introduction de Quervain39s tenosynovitis is a stenosing tenosynovitis of the first extensor compartment of the wrist and leads to wrist pain along with impaired function of the wrist and hand Local steroid injection and...
Interleukin-6 blocker for successful outcome of late-onset rheumatoid oligoarthritis
Newer cytokine therapies have revolutionised the management of Rheumatoid arthritis. Atypical oligoarthritis can also be a manifestation of RA and CCP antibodies have been proven to be most specific for Rheumatoid. Our p...